Tag: Paragraph IV certification

FDA's 180-Day Exclusivity: Benefits for First Generic Applicants

Beata Staszkow
|
March 31
|
0

Learn how FDA's 180-day exclusivity works for generic drug manufacturers, including eligibility, forfeiture risks, and upcoming regulatory reforms in the US market.